Eli Lilly (LLY) Total Debt (2009 - 2025)

Eli Lilly (LLY) has reported Total Debt for 17 consecutive years, with $42.5 billion the latest figure, recorded in FY2025.

• Total Debt for Q1 2026 came in at $43.4 billion, up 12.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.4 billion (up 12.6% YoY), and the FY2025 annual result was $42.5 billion, up 26.33% from the prior year.
• Total Debt was $42.5 billion for FY2025 at Eli Lilly, up from $33.6 billion in the prior year.
• Over five years, Total Debt peaked at $42.5 billion in FY2025 and troughed at $16.2 billion in FY2022.
• Average Total Debt over 5 years is $26.9 billion, with a median of $25.2 billion recorded in 2023.
• Year-over-year, Total Debt slipped 3.83% in 2022 and jumped 55.34% in 2023.
• Over 5 years, Total Debt stood at $16.9 billion in 2021, then dropped by 3.83% to $16.2 billion in 2022, then surged by 55.34% to $25.2 billion in 2023, then soared by 33.37% to $33.6 billion in 2024, then increased by 26.33% to $42.5 billion in 2025.
• Per Business Quant data, the three most recent Total Debt figures were $42.5 billion in FY2025, $33.6 billion in FY2024, and $25.2 billion in FY2023.